These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16422782)

  • 1. A comparison of multivariable regression models to analyse cost data.
    Dodd S; Bassi A; Bodger K; Williamson P
    J Eval Clin Pract; 2006 Feb; 12(1):76-86. PubMed ID: 16422782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of several regression models for analysing cost of CABG surgery.
    Austin PC; Ghali WA; Tu JV
    Stat Med; 2003 Sep; 22(17):2799-815. PubMed ID: 12939787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.
    Hallinen T; Martikainen JA; Soini EJ; Suominen L; Aronkytö T
    Curr Med Res Opin; 2006 Apr; 22(4):683-92. PubMed ID: 16684429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term persistence of high health care costs in a nationally representative sample of children.
    Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
    Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using multilevel models for assessing the variability of multinational resource use and cost data.
    Grieve R; Nixon R; Thompson SG; Normand C
    Health Econ; 2005 Feb; 14(2):185-96. PubMed ID: 15386660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New models for old questions: generalized linear models for cost prediction.
    Moran JL; Solomon PJ; Peisach AR; Martin J
    J Eval Clin Pract; 2007 Jun; 13(3):381-9. PubMed ID: 17518803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-part model for censored medical cost data.
    Tian L; Huang J
    Stat Med; 2007 Oct; 26(23):4273-92. PubMed ID: 17330248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme regression models for characterizing high-cost patients.
    Gregori D; Petrinco M; Barbati G; Bo S; Desideri A; Zanetti R; Merletti F; Pagano E
    J Eval Clin Pract; 2009 Feb; 15(1):164-71. PubMed ID: 19239597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computer program for estimating the re-transformed mean in heteroscedastic two-part models.
    Zhou XH; Cheng H
    Comput Methods Programs Biomed; 2008 Jun; 90(3):210-6. PubMed ID: 18355938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: the SOHO study.
    Windmeijer F; Kontodimas S; Knapp M; Brown J; Haro JM
    Int J Technol Assess Health Care; 2006; 22(4):460-8. PubMed ID: 16984679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.